Cannabis News

Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of Aurora Cannabis Inc. (NYSE: ACB) between February 13, 2020 and September 4, 2020, inclusive (the "Class Period"). If you wish to serve as lead plaintiff, you must move the Court before the December 1 2020 DEADLINE . A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

To join the class action, go to http://zhanginvestorlaw.com/join-action-form/?slug=aurora-cannabis-inc&id=2437 or call Sophie Zhang, Esq. toll-free at 800-991-3756 or email info@zhanginvestorlaw.com for information on the class action.

如果您想加入这个集体诉讼案,请在这里提交您的信息。 http://zhanginvestorlaw.com/join-action-form/?slug=aurora-cannabis-inc&id=2437

According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: Aurora had significantly overpaid for previous acquisitions and experienced degradation in certain assets, including its production facilities and inventory; the Company's purported "business transformation plan" and cost reset failed to mitigate the foregoing issues; accordingly, it was foreseeable that the Company would record significant goodwill and asset impairment charges; and as a result, the Company's public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

Lead plaintiff status is not required to seek compensation.  You may retain counsel of your choice.  You may remain an absent class member and take no action at this time.

Zhang Investor Law represents investors worldwide. Attorney Advertising. Prior results do not guarantee similar outcomes.

Zhang Investor Law P.C.
99 Wall Street, Suite 232
New York, New York 10005
info@zhanginvestorlaw.com
tel: (800) 991-3756


Primary Logo

News Provided by GlobeNewswire via QuoteMedia

Trulieve Opening Medical Marijuana Dispensary in Auburndale

New dispensary expands patient access to medical cannabis; grand opening specials available

9 p.m. from Monday through Saturday and 10 a.m8 p.m. on Sunday .

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less
Hygrovest

HGV Investment Portfolio Report July 2022

HGV Limited (ASX: HGV) ("HGV”)is an Australian-listed specialist investment company which concentrates on producing capital growth for shareholders over the medium term from investments in listed and unlisted equities and other financial assets.

Keep reading...Show less
VIDEO — HEXO CEO: Aggressive Pursuit of Clean Balance Sheet Has Reset Company

VIDEO — HEXO CEO: Aggressive Pursuit of Clean Balance Sheet Has Reset Company

It’s been a seriously difficult period for Canadian cannabis operators over the past few years, with volatility prevailing as the status quo for companies in the market.

Charlie Bowman, president and CEO of HEXO (NASDAQ:HEXO,TSX:HEXO), understands that, and that’s why his first order of business after taking the helm at the company was to clean up its finances. He sees a better path ahead for HEXO now that it has restructured its assets and had its debt purchased by a fellow Canadian producer.

Bowman spoke at length with the Investing News Network (INN) about the downturn in Canadian cannabis stocks, HEXO’s NASDAQ listing status and its partnership with Tilray Brands (NASDAQ:TLRY,TSX:TLRY).

Keep reading...Show less
Avicanna Reports Q2 2022 Financial Statement

Avicanna Reports Q2 2022 Financial Statement

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS

Avicanna Inc. (" Avicanna " or the " Company ") (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a commercial stage, international biopharmaceutical company focused on the commercialization of evidence-based, cannabinoid-based products, is pleased to announce the filing of its interim financial statements for the three-month period ending June 30, 2022 (" Q2 2022 ").

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less

Limited-Edition Pumpkin Spice CBD Wellness Gummies Arrive Just in Time for Fall As Martha Stewart CBD Expands Portfolio

New, classic fall flavor joins brand's best-selling lineup of CBD products

Today, Martha Stewart CBD unveiled the latest flavor in its CBD portfolio Pumpkin Spice CBD Wellness Gummies. Inspired by the most recognized flavor of the fall, these new gummies tap into the spirit of the season and are the perfect addition to consumers' favorite fall activities. These limited-edition gummies continue the expansion of the Martha Stewart CBD gummies lineup, which features some of the brands most popular items and flavors, including the Tropical Medley CBD Wellness Gummies™ and Harvest Medley CBD Wellness Gummies™.

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less
The Greenrose Holding Company Postpones Second Quarter 2022 Conference Call, Originally Scheduled for August 15, 2022 at 5:00 p.m. ET

The Greenrose Holding Company Postpones Second Quarter 2022 Conference Call, Originally Scheduled for August 15, 2022 at 5:00 p.m. ET

The Greenrose Holding Company Inc. (OTC: GNRS, GNRSW) ("Greenrose" or the "Company"), a multi-state grower and producer of cannabis brands and products announced that it will be postponing its scheduled conference call on Monday, August 15, 2022, at 5:00 p.m. Eastern time to discuss its results for the second quarter ended June 30, 2022.

Greenrose is committed to reporting its second quarter 2022 financial results and providing an update on timing for the rescheduled conference call as soon as practicable. The Company expects to issue revised call details once confirmed.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News

×